Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...

Recent research suggests that certain biologic medications called monoclonal antibodies may help treat emphysema more effectively than some current therapies. These medications include benralizumab ...

Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pulmonx Corporation (LUNG) (Nasdaq: LUNG) (“Pulmonx”), a global ...

Please provide your email address to receive an email when new articles are posted on . A variety of options/tools are needed when treating patients with severe emphysema and breathlessness. A phase 3 ...

As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for advanced emphysema may survive longer and with fewer complications than they did ...

Emphysematous changes refer to changes that may occur in the lungs as emphysema progresses and are visible on a CT scan. This may include changes in location or the type of damage in the lungs due to ...